Insider Stock Trading History of Hadjimichael Amalia


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hadjimichael Amalia since year 2005. The trader's CIK number is 1591257. At the time of this reporting, Hadjimichael Amalia is the of Karyopharm Therapeutics Inc. . (stock ticker symbol KPTI). See this page for all insider trading activities at Karyopharm Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Hadjimichael Amalia since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-26 KPTI Karyopharm Therapeutics Inc. Sale 50,000 42.93 2,146,550
2014-09-24 KPTI Karyopharm Therapeutics Inc. Sale 22,498 40.32 907,141
2014-09-17 KPTI Karyopharm Therapeutics Inc. Sale 9,569 40.26 385,267
2014-09-18 KPTI Karyopharm Therapeutics Inc. Sale 2,778 40.16 111,556
2014-09-08 KPTI Karyopharm Therapeutics Inc. Sale 35,666 39.92 1,423,608
2014-09-04 KPTI Karyopharm Therapeutics Inc. Sale 12,795 38.07 487,092
2014-08-26 KPTI Karyopharm Therapeutics Inc. Sale 22,239 38.80 862,784
2014-08-27 KPTI Karyopharm Therapeutics Inc. Sale 21,460 39.07 838,442
2014-08-25 KPTI Karyopharm Therapeutics Inc. Sale 4,389 38.08 167,150
2014-08-18 KPTI Karyopharm Therapeutics Inc. Sale 3,175 39.10 124,132
2014-08-14 KPTI Karyopharm Therapeutics Inc. Sale 200 38.04 7,609
2014-08-15 KPTI Karyopharm Therapeutics Inc. Sale 7,827 39.14 306,356
2014-08-11 KPTI Karyopharm Therapeutics Inc. Sale 36,979 37.30 1,379,353
2014-07-30 KPTI Karyopharm Therapeutics Inc. Sale 41,481 37.13 1,540,106
2014-07-30 KPTI Karyopharm Therapeutics Inc. Sale 21,570 36.20 780,941

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hadjimichael Amalia ( of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.